ArticleHistochemistry and cell biology2007
The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
Yukio Nishimura et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it